Blood Based Biomarkers as Predictive Factors for Hyperprogressive Disease

Purpose: With the widespread use of immunotherapy agents, we encounter treatment responses such as hyperprogression disease (HPD) that we have not seen with previous standard chemotherapy and targeted therapies. It is known that survival in patients with HPD is shorter than in patients without HPD....

Descripción completa

Detalles Bibliográficos
Autores principales: Yildirim, Hasan Cagri, Guven, Deniz Can, Aktepe, Oktay Halit, Taban, Hakan, Yilmaz, Feride, Yasar, Serkan, Aksoy, Sercan, Erman, Mustafa, Kilickap, Saadettin, Yalcin, Suayib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457309/
https://www.ncbi.nlm.nih.gov/pubmed/36079101
http://dx.doi.org/10.3390/jcm11175171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457309/
https://www.ncbi.nlm.nih.gov/pubmed/36079101
http://dx.doi.org/10.3390/jcm11175171

Ejemplares similares